Ganaplacide plus lumefantrine solid dispersion formulation: considerations for development and rollout

Due to reliance on antimalarials for clinical case management, drug resistance is a recurrent challenge for malaria control and elimination that requires relentless discovery and development of novel medicines with new modes of action.1 Since the widespread use of chloroquine in the 1950s, resistanc...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	The Lancet infectious diseases 2023-09, Vol.23 (9), p.990-992
Hauptverfasser:	Chen, Ingrid, Ishengoma, Deus S
Format:	Artikel
Sprache:	eng
Schlagworte:	Antimalarial agents Antiparasitic agents Chloroquine Drug dosages Drug resistance Effectiveness FDA approval Global health Infectious diseases Malaria Manufacturing Personal communication Public health Supply chains Vector-borne diseases
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!